Phospholipids and Electromagnetism in the management of autism and degenerative neurological diseases Victor A Marcial-Vega,MD Orlando,Florida, 2013

President’s Cancer Panel Report 2010

Integrative Medicine Centers n Cleveland Clinic n Johns Hopkins Hospital n UCLA n George Washington University n MD Anderson Cancer Center n MSK Cancer Center n Massage, Nutrition, Acupunture, Psycotherapy

Integrative Medicine n Recognizes a crucial environmental role of toxins in the etiology and/or worsening of most diseases n Ex. Carbon-Petroleum based energy production, plastics, pesticides, heavy metals.

Heavy Metals n Present in 100% of the population n Marker of other toxins present in organism n Higgins, Parts per trillion of mercury significant (up to 1/1,000,000,000,000) significant in production of disease

24 hour urine collections Puerto Rico, Marcial-Vega, et al, 2013 mmmmm Metals% from 51 patients Range(ug/g creatinine) Lead100% 52/ Mercury65% 34/ Aluminum92% 48/ Arsenic100% 52/ Cadmium98% 51/ Gadolinium71% 37/ Nickel65% 34/ Uranium33% 17/

Pre and Post EDTA Calcium metalsprepost Lead Mercury Aluminum Arsenic617 Gadolinium Nickel0.910 Uranium00.183

PROVOCATION WITH EDTA n Conventional medicine discourages provocation because of increased toxicity n They recommend diagnosis with blood n We have found the opposite n It is both diagnostic and therapeutic under strict nutritional conditions

IV Push with EDTA Calcium n 245 patients n n Median Age 57 n Dose range mg n Median 2.4 grams

IV Push with EDTA Calcium n 5 minute infusion/once a week n Lowering of total cholesterol, LDL 85% n Lowering of glucose levels 92% n Disappearance of joint pains 95% n More energy and sleeping better 100% n Marcial-Vega, 2013

Retrospective Review of a Rejuvenation Program in the Management of Cancer Victor A. Marcial-Vega, MD San Juan, Puerto Rico April 2013

Treatment Protocol n Nutritional Supplementation n Intravenous Vitamin C (+ or - EDTA) n Ozone/Hyperthermia showers

Intravenous Therapy n Vitamin C 20 grams n Vitamins B1, B6(100 mg), B12 (1000ug) n Sterile water(250 cc) n EDTA 2-6 cc(3g/21cc )

Intravenous Therapy n Three times a week n 20 gram weekly increases until 70 grams or tolerance is reached n Dose range grams

Ozone/Hyperthermia Showers n 5 days a week n 1/2 hour treatments n degrees Fahrenheit

Results n Age Range 8-80 years Median 56 years n Median Follow-up 18 months n Analysis on 40 patients

Initial Response n More than 50% reduction of tumor n Within 3 weeks n (A) 25/33= 76% n (B) 3/5 = 60% n (C) 1/2 = 50% n Overall = 72%

18 months results n No tumor after multiple recurrences 2/33 n Complete Response 6/33 n Partial 6/33 n Total 14/33=42%

Symptoms n Improvement in 80% first 2 weeks n Sustained at 5 months in 50%

Memory and Awareness n Most patients report an improvement in cognitive, memory and focusing n Brain characteristics n This is an indicator of correlation between toxins and brain function

n These protocols are not as effective for neurological diseases. Seemed like detoxification was not enough and tissue regeneration had to be adressed

Phospholipids n Plaquex n In the management of cardiovascular diseases and detoxification n Our clinic in Miami started managing and detoxing patients with IV phosphatidylcholine

Phenylbutyrate n Crosses the blood brain barrier n Can calm a child with self mutilation symptoms in minutes n Can resolve headaches in migraine patients n Adjunct in detoxing the brain

Patricia Kane, Ph. D. n Has done work managing neurological diseases with phosphatidylcholine, glutathione and methylcobalamin together with GCSF, erythropoietin, phenylbutyrate n Reversal of neurological situations doing protocol daily and up to three times a day

Neurological Diseases Adults n More than 85% of Alzheimer’s Disease patients will have an MRI or CT scan showing white matter changes consistent with small vessel ischemic disease. n A disease of brain toxicity n Fourth leading cause of death in Puerto Rico. 6 th in the USA

Alzheimer’s Disease n Gochi, Chlorella, Vitamin C and Lactobacillus n Alkalinizing Program n Intravenous phosphatidylcholine n mg IV Push or IV bag in D5W n MB12, Glutathione n Weekly

PEMF-100 n Pulsed electromagnetic frequency device n Detoxifies the cells n Reduces inflammation n Increases circulation n Increases cellular nutrient uptake n Promotes stem cell formation

Inspirstar n Device developed by Edward Kondrot, MD n Microcurrent Device n Wet towels around silver glove poles n Towels are placed in a sandwich technique or limb-limb, limb-trunk

Alzheimer’s n 25 patients n Marked improvement in 72% of the patients n 2 had no response (8%) n 20% Moderate response Phosphatidylcholine Phosphatidylcholine

Prognostic Factors n AGE n Performance Status

Prognostic Factors n Patients with Alzheimers in their 50’s have a 70%(2/3) chance of not responding and rapidly progressing to severe dementia within a year n Only 30% have responded, reversed all their symptoms and remained free of disease(1/3)

Prognostic Factors n If patients can carry a normal conversation and walk, they have more than 90% chance of responding favorably to this protocol n If they cannot carry a normal conversation and not walk well, they have a more than 90% chance of not responding

Dementia n 10 patients n Marked improvement in most of their cognitive capacities n Improvement in socialization and orientation to place n Last aspect to improve-Short term memory

Parkinson’s Disease n 5 patients n Steady improvement in the first 2 months in 3/5 n 1 patient –No change n 1 patient-Dramatic improvement and reversal of all symptoms with PTC and pulsed electromagnetic frequency n All patients now get PEMF

Zoster Neuropathy n Poor results in 7 patients treated with intravenous vitamin C and hydrogen peroxide n 1 patient treated with Inpirstar had near complete resolution of their symptoms after 6 treatments

Herpes Neuropathy Beguinning of a cold sore sensation with neuropathic severe pain from the lip up by lower outer jaw. Attacks typically start like this, pain worsens over 24 hours and the blister appears. After one hour of microcurrent, pain is gone and no blister appeared

Chemotherapy Induced Neuropathy n Cisplatin, Carboplatin associated n Very painful n Feet and hands n Does not respond well to analgesics

Randomized Study Glutathione n Stomach Cancer Patients n Randomized to IV glutathione before chemotherapy versus none n Placebo group-All developed neuropathy n Treated group 10% developed neuropathy n Also, non-statistically significant difference in survival

Neuropathy n Management with phosphatidylcholine n 10 patients n Weekly n Improvement in all patients in the first two treatments n Complete Resolution of pain in 8 pts. n The earlier the better

ALS n 8 patients n One-EDTA, IVC, H2O2-no response. Died in less than a year n 2 more with PTC-No response n 1 Pt. with 3x/day tx 15 txs. Week n First week regained vocal cord and swallowing movement

ALS n Stopped treatment after 3 months and deteriorated n One patient was stable for one year speaking and walking. Died from a fall n One patient improved and spasticity markedly improved with PTC and PEMF

ALS n Latest 2 patients n #1 in less than 2 weeks could understand previously unintelligible speech. Swallowing better. n Improved pulmonary function studies n #2 Could move extremities better in 2 weeks n Both had daily treatment

Side Effects n Temporary (minutes) dizziness-2 n Extravasation and burning that would last days, weeks and sclerose veins temporarily 4% n Months of sclerosing 3 patients

AUTISM n 1:37 in Puerto Rico n 1:50-75 in the USA n No more figures presented in CDC website since 2008 n Rapidly rising epidemic n Maybe related to aluminum and mercury in vaccines

AUTISM n 75 patients n 7 Did not complete treatment n Of the 68 remaining patients n Analysis n 75% trigered at 18 months of age related to vaccine booster doses

AUTISM n Eliminate sugar, complex carbohydrates n Start nutritional alkalinization n Intravenous phosphatidylcholine n mg a week n Glutathione IV 400 mg a week n Methylcobalamin 1000 ug n Folic acid 4 mg

AUTISM n After Weekly treatments n IV Phenylbutyrate mg in 100 cc/d5w n Continue if there was a steady improvement n Side effects- Rash in 2 patients. Glutathione eliminated in them and it resolved. They were both allergic to eggs

RESULTS

Frederick’s Ataxia n Hereditary disease n Poor prognosis n Progressive Degenerative Disease n 2 sisters 14, 16 years old n 5 treatments so far n Improvement in gait, fine motor movements and energy levels

CONCLUSIONS n Phospholipid therapy reverses the pathologic features of autism and other neurological diseases n Phenylbutyrate seems to detoxify the brain and has a calming effect in all patients n One to two years of therapy may reverse all symptoms completely

CONCLUSIONS n Minimal side effects (allergic reaction and itching in one patient) n Worsening of symptoms n Hypoglicemia that is prevented by eating before therapy